These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 20001475

  • 1. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.
    Axelsson R, Bach-Gansmo T, Castell-Conesa J, McParland BJ, Study Group.
    Acta Radiol; 2010 Feb; 51(1):40-6. PubMed ID: 20001475
    [Abstract] [Full Text] [Related]

  • 2. Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.
    Bach-Gansmo T, Danielsson R, Saracco A, Wilczek B, Bogsrud TV, Fangberget A, Tangerud A, Tobin D.
    J Nucl Med; 2006 Sep; 47(9):1434-9. PubMed ID: 16954550
    [Abstract] [Full Text] [Related]

  • 3. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL, Kara PO, Gedik GK, Kars A, Türker A, Caner B.
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [Abstract] [Full Text] [Related]

  • 4. 99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study.
    Zhu Z, Miao W, Li Q, Dai H, Ma Q, Wang F, Yang A, Jia B, Jing X, Liu S, Shi J, Liu Z, Zhao Z, Wang F, Li F.
    J Nucl Med; 2012 May; 53(5):716-22. PubMed ID: 22499615
    [Abstract] [Full Text] [Related]

  • 5. Imaging of Integrin αvβ3 Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer 99mTc-IDA-D-[c(RGDfK)]2.
    Song YS, Park HS, Lee BC, Jung JH, Lee HY, Kim SE.
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [Abstract] [Full Text] [Related]

  • 6. Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.
    Dearling JL, Barnes JW, Panigrahy D, Zimmerman RE, Fahey F, Treves ST, Morrison MS, Kieran MW, Packard AB.
    Nucl Med Biol; 2013 Aug; 40(6):788-94. PubMed ID: 23701702
    [Abstract] [Full Text] [Related]

  • 7. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Aug; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of 99mTc-3PRGD2 integrin receptor imaging with 99mTc-MDP bone scan in diagnosis of bone metastasis in patients with lung cancer: a multicenter study.
    Miao W, Zheng S, Dai H, Wang F, Jin X, Zhu Z, Jia B.
    PLoS One; 2014 Aug; 9(10):e111221. PubMed ID: 25338281
    [Abstract] [Full Text] [Related]

  • 11. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
    Wang F, Wang Z, Yao W, Xie H, Xu J, Tian L.
    J Nucl Med; 2007 Sep; 48(9):1442-8. PubMed ID: 17704242
    [Abstract] [Full Text] [Related]

  • 12. Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.
    Sah BR, Schibli R, Waibel R, von Boehmer L, Bläuenstein P, Nexo E, Johayem A, Fischer E, Müller E, Soyka JD, Knuth AK, Haerle SK, Schubiger PA, Schaefer NG, Burger IA.
    J Nucl Med; 2014 Jan; 55(1):43-9. PubMed ID: 24337606
    [Abstract] [Full Text] [Related]

  • 13. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 14. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
    Karanikas G, Köstler WJ, Becherer A, Wiesner K, Dudczak R, Krainer M, Kletter K.
    Oncol Rep; 2002 Apr; 9(5):1009-13. PubMed ID: 12168065
    [Abstract] [Full Text] [Related]

  • 15. A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.
    Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
    Chen B, Zhao G, Ma Q, Ji B, Ji T, Xin H, Gao S.
    Int J Clin Exp Pathol; 2015 Nov; 8(12):16064-72. PubMed ID: 26884883
    [Abstract] [Full Text] [Related]

  • 18. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
    Ji T, Sun Y, Chen B, Ji B, Gao S, Ma Q, Cheng G, Zhang H.
    Hell J Nucl Med; 2015 Nov; 18(2):108-13. PubMed ID: 26187209
    [Abstract] [Full Text] [Related]

  • 19. [Detection of melanoma metastases with Tc-99m-tetrofosmin].
    Rettenbacher L, Koller J, Kässmann H, Galvan G.
    Nuklearmedizin; 2000 Nov; 39(4):97-101. PubMed ID: 10919159
    [Abstract] [Full Text] [Related]

  • 20. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
    Liu Z, Huang J, Dong C, Cui L, Jin X, Jia B, Zhu Z, Li F, Wang F.
    Mol Pharm; 2012 May 07; 9(5):1409-17. PubMed ID: 22452411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.